International Chemical Investors Group
  • HOME
  • OUR APPROACH
  • OUR INVESTMENTS
    • Our Platforms
    • Companies
    • ICIG Ventures
  • NEWS
  • CONTACT

ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group

by Infrastructure Support | Jul 26, 2019 | News

26. July 2019 CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce the appointment of Dr. Michael Quirmbach as Chief Executive Officer & President, effective...

LATEST ICIG NEWS

Biotech company Mevaldi successfully closes funding round with HTGF and ICIG Ventures to scale up breakthrough technology for green chemistry

10 September 2025 Geleen, the Netherlands – Dutch biotech company Mevaldi B.V. has closed a funding round with High-Tech Gründerfonds (HTGF) and ICIG Ventures, the...

Cooperation Agreement to Advance Photocatalytic Technologies in Chemical Manufacturing

12 August 2025 Frankfurt, Germany and Fort Collins, Colorado, USA. ICIG Ventures, the venture capital arm of International Chemical Investors Group (ICIG), today...

Vynova wins two prestigious Polymer Producers Awards

17 June 2025 For the fourth time in its history, Vynova was named best PVC producer at the Best Polymer Producers Awards for Europe. In addition, the company won the...

Corden BioChem is making an initial investment of double-digit million EUR to restart the bioethanol plant in Podari, Dolj County

Podari, 28 April 2025 Corden BioChem, a European leader in industrial biotechnology, announces a strategic investment in Romania through the acquisition of a...

⤏ All News